Joint (NASDAQ:JYNT) Raised to "Strong-Buy" at Wall Street Zen

Key Points

• Wall Street Zen upgraded Joint to “strong-buy” from “buy,” although the broader analyst consensus remains “Hold,” with three analysts currently assigning that rating.
• Joint reported quarterly EPS of $0.05, matching estimates, while revenue of $15.18 million exceeded the $14.57 million consensus forecast. Shares opened at $8.33, up 1.3%, with a market capitalization of approximately $118.8 million.
• Insider and institutional ownership remains significant: a major shareholder increased his position by 7.76%, while insiders own 30.20% and institutions and hedge funds own 76.88% of the stock.

Joint (NASDAQ:JYNT - Get Free Report) was upgraded by Wall Street Zen from a "buy" rating to a "strong-buy" rating in a research note issued on Saturday.

Other equities research analysts have also issued reports about the stock. Zacks Research lowered shares of Joint from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 7th. Weiss Ratings upgraded shares of Joint from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Friday, June 12th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold".

Joint Stock Up 1.3%

Shares of JYNT opened at $8.33 on Friday. The stock has a market capitalization of $118.79 million, a P/E ratio of 30.85 and a beta of 1.10. Joint has a twelve month low of $7.50 and a twelve month high of $11.26. The company has a 50 day moving average of $8.76 and a 200-day moving average of $8.87.

Joint (NASDAQ:JYNT - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.05 EPS for the quarter, hitting analysts' consensus estimates of $0.05. Joint had a net margin of 6.49% and a return on equity of 11.70%. The business had revenue of $15.18 million for the quarter, compared to analyst estimates of $14.57 million. On average, sell-side analysts anticipate that Joint will post 0.51 earnings per share for the current fiscal year.

Insider Activity

In related news, major shareholder Charles E. Jobson acquired 127,676 shares of the company's stock in a transaction dated Tuesday, May 12th. The shares were bought at an average price of $8.57 per share, for a total transaction of $1,094,183.32. Following the purchase, the insider directly owned 1,773,479 shares in the company, valued at approximately $15,198,715.03. This trade represents a 7.76% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 30.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Joint

Institutional investors have recently added to or reduced their stakes in the company. BNP Paribas Financial Markets raised its position in Joint by 104.7% during the third quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company's stock worth $28,000 after acquiring an additional 1,501 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Joint by 32.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company's stock valued at $86,000 after acquiring an additional 1,810 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Joint by 25.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company's stock valued at $95,000 after acquiring an additional 1,698 shares during the period. XTX Topco Ltd acquired a new position in shares of Joint during the 4th quarter worth about $124,000. Finally, Wells Fargo & Company MN increased its stake in shares of Joint by 78.0% during the 4th quarter. Wells Fargo & Company MN now owns 15,476 shares of the company's stock worth $135,000 after purchasing an additional 6,784 shares during the last quarter. 76.88% of the stock is currently owned by institutional investors and hedge funds.

About Joint

The Joint Chiropractic, Inc, doing business as Joint NASDAQ: JYNT, is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint's growth strategy centers on partnering with franchisees to expand its network of clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source